Announcement

Mark Tullis

Mark is Co-founder/Editor of TechBuzz News. From Ogden, UT, Mark attended WSU, BYU, and Tufts. He has been involved in tech, media, publishing since the 80s.

Location Lehi, UT
Number of Articles 2528
Socials
Mark Tullis's Work 2528 Articles
Ecosystem   -   Jun 28, 2025 Powering Utah’s Future: Overcoming Infrastructure Barriers to Lead in AI and Energy Innovation
Powering Utah’s Future: Overcoming Infrastructure Barriers to Lead in AI and Energy Innovation

Exploring critical infrastructure and legislative barriers limiting energy innovation, panelists at an energy strategy briefing discussed collaborative solutions and regulatory reform as essential to positioning Utah as a global leader in AI, data centers, and clean power deployment.

by Mark Tullis
Ecosystem   -   Jun 28, 2025 Powering Utah’s Future: Overcoming Infrastructure Barriers to Lead in AI and Energy Innovation
Powering Utah’s Future: Overcoming Infrastructure Barriers to Lead in AI and Energy Innovation

Exploring critical infrastructure and legislative barriers limiting energy innovation, panelists at an energy strategy briefing discussed collaborative solutions and regulatory reform as essential to positioning Utah as a global leader in AI, data centers, and clean power deployment.

by Mark Tullis
Tech News   -   Jun 27, 2025 Nusano Signs Multi-Isotope Supply Agreement with Cellectar Biosciences to Fuel Cancer Drug Development
Nusano Signs Multi-Isotope Supply Agreement with Cellectar Biosciences to Fuel Cancer Drug Development

Nusano (West Valley City, UT) will supply isotopes iodine-125 and actinium-225 to Cellectar Biosciences (Florham Park, NJ) under a new agreement, supporting development of radiotherapeutics including CLR 125 for breast cancer and CLR 225 for pancreatic cancer.

by Mark Tullis
Tech News   -   Jun 27, 2025 Nusano Signs Multi-Isotope Supply Agreement with Cellectar Biosciences to Fuel Cancer Drug Development
Nusano Signs Multi-Isotope Supply Agreement with Cellectar Biosciences to Fuel Cancer Drug Development

Nusano (West Valley City, UT) will supply isotopes iodine-125 and actinium-225 to Cellectar Biosciences (Florham Park, NJ) under a new agreement, supporting development of radiotherapeutics including CLR 125 for breast cancer and CLR 225 for pancreatic cancer.

by Mark Tullis
Money   -   Jun 26, 2025 Amplēo Accelerates National Expansion with Strategic Backing from Unity Partners
Amplēo Accelerates National Expansion with Strategic Backing from Unity Partners

Amplēo (Lehi, UT) has secured a strategic investment from Unity Partners LP (Dallas, TX) to accelerate growth, expand services, and boost national reach in fractional finance, marketing, HR, and valuation—cementing its leadership in managed professional services.

by Mark Tullis
Money   -   Jun 26, 2025 Amplēo Accelerates National Expansion with Strategic Backing from Unity Partners
Amplēo Accelerates National Expansion with Strategic Backing from Unity Partners

Amplēo (Lehi, UT) has secured a strategic investment from Unity Partners LP (Dallas, TX) to accelerate growth, expand services, and boost national reach in fractional finance, marketing, HR, and valuation—cementing its leadership in managed professional services.

by Mark Tullis
Money   -   Jun 26, 2025 Sorenson Capital Launches $150M Ventures III Fund with Continued Focus on Cybersecurity and B2B Software
Sorenson Capital Launches $150M Ventures III Fund with Continued Focus on Cybersecurity and B2B Software

Sorenson Capital (Lehi, UT and Palo Alto, CA) has launched its $150M Ventures III fund, reaffirming its focused investment strategy in early-stage cybersecurity and B2B software startups, emphasizing hands-on support, consistent fund sizing, and long-term sector expertise.

by Mark Tullis
Money   -   Jun 26, 2025 Sorenson Capital Launches $150M Ventures III Fund with Continued Focus on Cybersecurity and B2B Software
Sorenson Capital Launches $150M Ventures III Fund with Continued Focus on Cybersecurity and B2B Software

Sorenson Capital (Lehi, UT and Palo Alto, CA) has launched its $150M Ventures III fund, reaffirming its focused investment strategy in early-stage cybersecurity and B2B software startups, emphasizing hands-on support, consistent fund sizing, and long-term sector expertise.

by Mark Tullis
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Great! You've successfully signed up.
Great! You've successfully signed up.
Welcome back! You've successfully signed in.
Success! You now have access to additional content.